Apararenone Chemical Structure oral nonsteroidal MR antagonist - Mitsubishi Tanabe Pharma Corporation, Yokohama, JP

oral nonsteroidal MR antagonist

Ph. II candidate in DN and NASH (discontinued)

previous literature and hypothesis-driven opt.

J. Med. Chem.

Mitsubishi Tanabe Pharma Corporation, Yokohama, JP

Context. Apararenone (Mitsubishi Tanabe) is an oral nonsteroidal mineralocorticoid receptor (MR) antagonist. Agents with the ability to modulate the nuclear receptor MR have been pursued for at least 80…


 this content is exclusive to
Premium members

Upgrade to a Premium Drug Hunter membership to unlock the full content and start reading now.